The hTERTα splice variant is a dominant negative inhibitor of telomerase activity

被引:182
作者
Colgin, LM
Wilkinson, C
Englezou, A
Kilian, A
Robinson, MO
Reddel, RR
机构
[1] Childrens Med Res Inst, Westmead, NSW 2145, Australia
[2] CAMBIA, Canberra, ACT 2601, Australia
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
NEOPLASIA | 2000年 / 2卷 / 05期
关键词
telomerase; telomeres; hTERT; splicing; dominant negative;
D O I
10.1038/sj.neo.7900112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERT alpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERT alpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 32 条
  • [1] ap Rhys C M, 1996, EXS, V77, P289
  • [2] Avilion AA, 1996, CANCER RES, V56, P645
  • [3] LETHALITY INDUCED BY A SINGLE SITE-SPECIFIC DOUBLE-STRAND BREAK IN A DISPENSABLE YEAST PLASMID
    BENNETT, CB
    LEWIS, AL
    BALDWIN, KK
    RESNICK, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5613 - 5617
  • [4] The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit
    Bryan, TM
    Marusic, L
    Bacchetti, S
    Namba, M
    Reddel, RR
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (06) : 921 - 926
  • [5] TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY
    BRYAN, TM
    ENGLEZOU, A
    GUPTA, J
    BACCHETTI, S
    REDDEL, RR
    [J]. EMBO JOURNAL, 1995, 14 (17) : 4240 - 4248
  • [6] Telomere maintenance mechanisms and cellular immortalization
    Colgin, LM
    Reddel, RR
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) : 97 - 103
  • [7] The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter
    Cong, YS
    Wen, JP
    Bacchetti, S
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (01) : 137 - 142
  • [8] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929
  • [9] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367
  • [10] Inhibition of telomerase limits the growth of human cancer cells
    Hahn, WC
    Stewart, SA
    Brooks, MW
    York, SG
    Eaton, E
    Kurachi, A
    Beijersbergen, RL
    Knoll, JHM
    Meyerson, M
    Weinberg, RA
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1164 - 1170